Cite

HARVARD Citation

    Chehade, M. et al. (n.d.). S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE. American journal of gastroenterology. pp. e316-e317. [Online]. 
  
Back to record